188 related articles for article (PubMed ID: 36361897)
1. The Crystal Structure of Mouse Ces2c, a Potential Ortholog of Human CES2, Shows Structural Similarities in Substrate Regulation and Product Release to Human CES1.
Eisner H; Riegler-Berket L; Gamez CFR; Sagmeister T; Chalhoub G; Darnhofer B; Jazleena PJ; Birner-Gruenberger R; Pavkov-Keller T; Haemmerle G; Schoiswohl G; Oberer M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361897
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
3. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
[TBL] [Abstract][Full Text] [Related]
5. The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.
Shen Y; Eades W; Liu W; Yan B
Drug Metab Dispos; 2022 Sep; 50(9):1151-1160. PubMed ID: 35790245
[TBL] [Abstract][Full Text] [Related]
6. Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease.
Chalhoub G; Kolleritsch S; Maresch LK; Taschler U; Pajed L; Tilp A; Eisner H; Rosina P; Kien B; Radner FPW; Schicho R; Oberer M; Schoiswohl G; Haemmerle G
J Lipid Res; 2021; 62():100075. PubMed ID: 33872605
[TBL] [Abstract][Full Text] [Related]
7. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
[TBL] [Abstract][Full Text] [Related]
8. Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.
Holmes RS; Chan J; Cox LA; Murphy WJ; VandeBerg JL
BMC Evol Biol; 2008 Feb; 8():54. PubMed ID: 18289373
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
[TBL] [Abstract][Full Text] [Related]
10. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.
Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK
Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868
[TBL] [Abstract][Full Text] [Related]
12. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells.
Shang W; Liu J; Chen R; Ning R; Xiong J; Liu W; Mao Z; Hu G; Yang J
Xenobiotica; 2016; 46(5):393-405. PubMed ID: 26340669
[TBL] [Abstract][Full Text] [Related]
14. Examination of the carboxylesterase phenotype in human liver.
Ross MK; Borazjani A; Wang R; Crow JA; Xie S
Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.
Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF
Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172
[TBL] [Abstract][Full Text] [Related]
16. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
17. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
[TBL] [Abstract][Full Text] [Related]
18. Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.
Zhu HJ; Appel DI; Jiang Y; Markowitz JS
Drug Metab Dispos; 2009 Sep; 37(9):1819-25. PubMed ID: 19487248
[TBL] [Abstract][Full Text] [Related]
19. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans.
Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M
Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089
[TBL] [Abstract][Full Text] [Related]
20. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Merali Z; Ross S; Paré G
Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
